Fig. 4From: Community-led Responses for Elimination (CoRE): a study protocol for a community randomized controlled trial assessing the effectiveness of community-level, reactive focal drug administration for reducing Plasmodium falciparum infection prevalence and incidence in Southern Province, ZambiaParticipant flow chart to determine antimalarial treatment regimen under reactive focal mass drug administration (RFDA) with DHAP. WRA (15–49 years) women of reproductive age 15 to 49 years old; mRDT malaria rapid diagnostic test, HC health center, AL artemether-lumefantrine, DHAP dihydroartemethesin-piperaquine. *Individual will be offered standard of care (see Fig. 3)Back to article page